Clinical trial
Antidepressant Effects of NR2B in Major Depression
NCT00472576 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00472576 |
|---|---|
| Title | Antidepressant Effects of NR2B in Major Depression |
| Official title | An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | MK-0657, Placebo |
| Enrollment | 5 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 11, 2007 |
| Last update posted | Aug 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: